SJ Corporation Ltd has successfully completed its preferential allotment of equity shares, raising ₹42,00,00,000 through the issuance of 3,50,00,000 equity shares. The Board of Directors approved the allotment on March 13, 2026, marking a significant capital raising exercise for the Mumbai-based company.

Share Allotment Details

The preferential allotment involved the issuance of 3,50,00,000 equity shares at a face value of Re.1/- each, priced at ₹12 per share including a premium of ₹11. The allotment was conducted following the special resolution passed in the Extraordinary General Meeting held on March 02, 2026, and pursuant to BSE Limited's in-principal approval letter dated March 09, 2026.

Capital Structure Transformation

The preferential allotment has resulted in a substantial increase in the company's paid-up capital. Prior to the allotment, SJ Corporation's paid-up capital stood at ₹83,55,000, comprising 83,55,000 equity shares of face value Re.1/- each. Post allotment, the paid-up capital has increased to ₹4,33,55,000, representing 4,33,55,000 equity shares of face value Re.1/- each.

Investor Composition

The allotment was made to 11 investors comprising both promoters and non-promoters. The major allottees include:

Promoter Group:

• Pintu Kanjibhai Kalavadia: 82,11,874 shares (18.94%)
• Prashant K Kalavadia: 82,11,874 shares (18.94%)
• Umang Kantilal Savani: 42,61,202 shares (9.83%)
• Kalpesh Patel: 10,15,050 shares (2.34%)

Non-Promoter Investors:

• Falguni Chandresh Lotia and Chandresh Lotia (Pranir Investments): 72,00,000 shares (16.61%)
• Quantam Strategic Advisors LLP: 28,50,000 shares (6.57%)
• Apex Advisors LLP: 27,50,000 shares (6.34%)
• Individual investors from Dholakia family: 5,00,000 shares collectively

Regulatory Compliance

The company has fulfilled all regulatory requirements for the preferential allotment. The newly allotted equity shares rank pari passu with the existing equity shares of the company. The disclosure was made in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and SEBI Circular dated July 13, 2023.

The Board meeting for approving the allotment commenced at 04.30 P.M. and concluded at 05.00 P.M. on March 13, 2026. The company has received the full consideration amount of ₹42,00,00,000 for the allotment as per the terms of the issue.

SJ Corporation Limited has successfully obtained regulatory approval for amendments to its foundational corporate documents, marking a significant milestone in the company's corporate governance journey.

Shareholder Approval Process

The amendment process began with shareholder consultation, where the company's shareholders approved the alteration of the Main Object Clause in the Memorandum of Association through a postal ballot dated March 07, 2026. The approval was secured via special resolution, demonstrating strong stakeholder support for the proposed changes.

Regulatory Approval Details

The Ministry of Corporate Affairs (MCA) granted its approval for the alteration through an official letter dated March 12, 2026. The regulatory body issued a Certificate of Registration of the Special Resolution Confirming Alteration of Object Clause(s) under Section 13(1) of the Companies Act, 2013.

Corporate Communication

SJ Corporation Limited formally communicated this development to BSE Limited on March 13, 2026, in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The notification was signed by Deepak Upadhyay, Managing Director (DIN: 02270389), ensuring proper corporate authorization.

Company Information

SJ Corporation Limited operates from its registered office at 201, Shyam Bungalow, Plot No.199/200, Pushpa Colony, Fatimadevi School Lane, Manchubhai Road, Malad (East), Mumbai - 400097. The company holds Corporate Identity Number L19201MH1981PLC452533 and trades on BSE with script code 504398 under the symbol SJCORP.

The successful completion of this amendment process reflects the company's commitment to maintaining proper corporate governance standards and regulatory compliance while adapting its corporate structure to meet evolving business requirements.